 |
PDBsum entry 1cx3
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
38:15104-15115
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution structure and dynamics of a complex between DNA and the antitumor bisnaphthalimide LU-79553: intercalated ring flipping on the millisecond time scale.
|
|
J.Gallego,
B.R.Reid.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Using a combination of nuclear magnetic resonance (NMR) spectroscopy experiments
and molecular dynamics, we have analyzed the structure and dynamics of a complex
between the bisnaphthalimide drug LU-79553 and the DNA duplex d(ATGCAT)(2).
LU-79553 is a DNA-binding topoisomerase II inhibitor that is particularly
effective against human solid tumors that are refractory to other drugs. We have
found that the two naphthalimide chromophores of the drug bisintercalate at the
TpG and CpA steps of the DNA hexanucleotide, stacking mainly with the purine G
and A bases from opposite strands. The 3, 7-diazanonylene linker lies in the
major groove of the DNA molecule, with its two amino groups hydrogen-bonded to
the symmetry-related guanine bases. Unexpectedly, we have detected an
unprecedented exchange process between two equivalent and intercalated states of
the naphthalimide rings in the drug-DNA complex. The interconversion process
takes place by rotational ring flipping, has an activation energy of 22 kcal
mol(-)(1) for the two rings, and does not affect the aminoalkyl linker region of
the drug. The exchange rate is intermediate to fast on the chemical shift time
scale at 36 degrees C (1800 s(-)(1)) but slow at 2 degrees C (20 s(-)(1)). We
have also observed limited flexibility for the drug linker on the picosecond
time scale on the basis of NMR data and a time-averaged restrained molecular
dynamics simulation. The implications of the structural and dynamic features of
the DNA-LU-79553 complex on the binding specificity and on the antitumor
activity of bisnaphthalimide agents are discussed.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Rettig,
W.Langel,
A.Kamal,
and
K.Weisz
(2010).
NMR structural studies on the covalent DNA binding of a pyrrolobenzodiazepine-naphthalimide conjugate.
|
| |
Org Biomol Chem,
8,
3179-3187.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.McMasters,
and
L.A.Kelly
(2007).
Sequence-dependent interactions of cationic naphthalimides and polynucleotides.
|
| |
Photochem Photobiol,
83,
889-896.
|
 |
|
|
|
|
 |
S.L.Woodhouse,
E.J.Ziolkowski,
and
L.M.Rendina
(2005).
Synthesis and anti-cancer activity of dinuclear platinum(II) complexes containing bis(thioalkyl)dicarba-closo-dodecaborane(12) ligands.
|
| |
Dalton Trans,
(),
2827-2829.
|
 |
|
|
|
|
 |
J.Dai,
C.Punchihewa,
P.Mistry,
A.T.Ooi,
and
D.Yang
(2004).
Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug.
|
| |
J Biol Chem,
279,
46096-46103.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Gallego
(2004).
Sequence-dependent nucleotide dynamics revealed by intercalated ring rotation in DNA-bisnaphthalimide complexes.
|
| |
Nucleic Acids Res,
32,
3607-3614.
|
 |
|
|
|
|
 |
W.A.Denny
(2004).
Emerging DNA topisomerase inhibitors as anticancer drugs.
|
| |
Expert Opin Emerg Drugs,
9,
105-133.
|
 |
|
|
|
|
 |
C.Carrasco,
A.Joubert,
C.Tardy,
N.Maestre,
M.Cacho,
M.F.Braña,
and
C.Bailly
(2003).
DNA sequence recognition by bispyrazinonaphthalimides antitumor agents.
|
| |
Biochemistry,
42,
11751-11761.
|
 |
|
|
|
|
 |
S.T.Hoehn,
H.D.Junker,
R.C.Bunt,
C.J.Turner,
and
J.Stubbe
(2001).
Solution structure of Co(III)-bleomycin-OOH bound to a phosphoglycolate lesion containing oligonucleotide: implications for bleomycin-induced double-strand DNA cleavage.
|
| |
Biochemistry,
40,
5894-5905.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
V.Guelev,
J.Lee,
J.Ward,
S.Sorey,
D.W.Hoffman,
and
B.L.Iverson
(2001).
Peptide bis-intercalator binds DNA via threading mode with sequence specific contacts in the major groove.
|
| |
Chem Biol,
8,
415-425.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |